Low toxicity and excellent outcomes in patients with DLBCL without residual lymphoma at the time of CD19 CAR T-cell therapy

Autor: Perales, Miguel-Angel, Maziarz, Richard T., Riedell, Peter A., McGuirk, Joseph P., Bachanova, Veronika, Porter, David L., Nastoupil, Loretta J., Oluwole, Olalekan O., Wudhikarn, Kitsada, Tomas, Ana Alarcon, Flynn, Jessica R., Devlin, Sean M., Brower, Jamie, Schuster, Stephen J., Bishop, Michael R.
Zdroj: In Blood Advances 11 July 2023 7(13):3192-3198
Databáze: ScienceDirect